CD74 is associated with inflamed tumor immune microenvironment and predicts responsiveness to PD-1/CTLA-4 bispecific antibody in patients with solid tumors
Jianghua Wang(Huazhong Agricultural University), Baiyong Li(China National Pharmaceutical Group Corporation (China))
Cited by 19
Related Papers
FGF23 promotes prostate cancer progression
|Oncotarget|2015|89
Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model
|Journal of Clinical Investigation|2016|79
MNX1 Is Oncogenically Upregulated in African-American Prostate Cancer
|Cancer Research|2016|66